Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT-HF: Carvedilol in childhood cancer survivors
NCT02717507Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Apr 2016
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of carvedilol in heart failure (HF), sponsored by Children's Oncology Group. Started Apr 2016; status: completed.
02
Drugs
carvedilol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02717507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02717507.